Marcy-l’Étoile (France) – bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced […]
ATLANTA — Axion BioSystems, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging systems, announces the acquisition of the intellectual property and assets of CytoTronics, Inc. The purchase brings novel high-density (HD) electrode array technology developed at Harvard University to Axion’s growing product suite and strengthens Axion’s ability to provide […]
New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights SEATTLE — Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker™. The new functionality complements Parse’s […]
A compact platform reduces the cost and infrastructure typically required for advanced genomics research, expanding access for startups, academic and incubator labs, and enterprise R&D teams. Beverly, MA – RAN Biotechnologies, a science-driven innovator in advanced micro- and nano-materials and microfluidic systems, today announced the launch of the OrchestRANum™ System, a new line of products designed […]
DAVIS, Calif. — Antibodies Inc., a leading supplier of validated life science research reagents, today announced the availability of its Recombinant Guinea Pig RBPMS Antibody (Clone OTI3B7-GP, Cat. No. 1834-RBPMS)—a next-generation antibody designed to deliver superior reproducibility, specificity, and performance in retinal ganglion cell (RGC) research. Developed under the PhosphoSolutions brand, the recombinant Guinea Pig RBPMS Antibody continues […]
HOUSTON — Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo® TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution designed to accelerate kinase activity detection and high-throughput kinase inhibitor screening. Leveraging advanced Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, these kits deliver exceptional sensitivity, low background, and robust reproducibility. This enables rapid, reliable, […]
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes SEATTLE & VIENNA — Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will leverage Graph’s lab-in-the-loop platform with Parse’s […]
Amsbio announces a new range of well characterized Adeno-Associated Virus (AAV) reference standards that enable researchers to significantly improve their AAV production processes. Adeno-associated virus can be engineered to transport DNA of interest to target cells, without any viral genes – making them a highly desirable and safe tool for gene therapy. However, one of the greatest challenges […]
Abcam has joined an industry-academic partnership led by the Structural Genomics Consortium and Pfizer to advance AI-driven drug discovery through open science, a new public-private partnership with a budget of more than €60 million. Through this collaboration, the Innovative Health Initiative Project LIGAND‑AI will generate large, high-quality protein–ligand datasets to support the development of predictive […]
The FDA-approved comprehensive genomic profiling test will be reimbursed at a rate of $2,989.55 per test, helping to advance adoption in the US healthcare system SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic (IVD) TruSight™ Oncology (TSO) Comprehensive test. The reimbursement decision from the Centers for […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
